News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Jeffrey Leiden M.D., Ph.D. and Dennis Winger Join Vertex Pharmaceuticals Incorporated’s Board of Directors
July 8, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced that Jeffrey Leiden, M.D., Ph.D. and Dennis Winger joined its board of directors.
Twitter
LinkedIn
Facebook
Email
Print
People
Vertex Pharmaceuticals
MORE ON THIS TOPIC
Rare diseases
Neurocrine defends Prader-Willi drug after another patient death
November 3, 2026
·
3 min read
·
Annalee Armstrong
Deals
Novartis puts $772M BioArctic deal on ice, skates away from brain-delivery alliance
November 3, 2026
·
1 min read
·
Gabrielle Masson
Earnings
Pfizer flat in Q3 despite 32% growth for new and acquired products
November 3, 2026
·
2 min read
·
Annalee Armstrong
Business
Karyopharm files for bankruptcy, looks to merger with Ayrmid for life raft
November 2, 2026
·
3 min read
·
Angela Gabriel